Inactive Instrument

Sedana Medical AB (publ) Share Price Nasdaq Stockholm

Equities

Medical Equipment, Supplies & Distribution

End-of-day quote Nasdaq Stockholm
- SEK - Intraday chart for Sedana Medical AB (publ)

Financials

Sales 2024 * 188M 17.29M 0 Sales 2025 * 239M 22.07M 0 Capitalization 2.2B 203M 0
Net income 2024 * -53M -4.88M - Net income 2025 * -42M -3.87M - EV / Sales 2024 * 10.5 x
Net cash position 2024 * 223M 20.55M 0 Net cash position 2025 * 94.2M 8.68M 0 EV / Sales 2025 * 8.79 x
P/E ratio 2024 *
-42.1 x
P/E ratio 2025 *
-50.7 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 63.5%
More Fundamentals * Assessed data

Latest transcript on Sedana Medical AB (publ)

Managers TitleAgeSince
Chief Executive Officer 43 30/09/21
Director of Finance/CFO - 03/04/22
Chief Tech/Sci/R&D Officer 53 31/10/20
Members of the board TitleAgeSince
Director/Board Member 65 31/12/21
Director/Board Member 49 18/05/20
Chairman 53 09/05/21
More insiders
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
Calendar
More about the company